5-aminolevulinic acid and neuronavigation in high-grade glioma surgery: Results of a combined approach

Neurocirugia

Volumn 23, Issue 1, 2012, Pages 23-28

  Panciani, Pier Paolo ^a   Fontanella, Marco ^a   Garbossa, Diego ^a   Agnoletti, Alessandro ^a   Ducati, Alessandro ^a   Lanotte, Michele ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

5 aminolevulinic acid; Gross total; High grade glioma surgery; Neuronavigation

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURGERY; CLINICAL ARTICLE; FLUORESCENCE; GLIOMA; HUMAN; HUMAN TISSUE; NEURONAVIGATION; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; BRAIN TUMOR; REPRODUCIBILITY;

AMINOLEVULINIC ACID; BRAIN NEOPLASMS; GLIOMA; HUMANS; NEURONAVIGATION; REPRODUCIBILITY OF RESULTS;

EID: 84864244944     PISSN: 11301473     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neucir.2012.04.003     Document Type: Article

References (13)

1. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients withglioblastoma multiforme: prognosis, extent of resection, andsurvival. J Neurosurg. 2001;95:190-8. (Pubitemid 32799739)
2. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. 5 ALA-Glioma Study Group: Fluorescence-guidedsurgery with 5-aminolevulinic acid for resection of malignantglioma: a randomised controlled multicentre phase III trial.Lancet Oncol. 2006;7:392-401.
3. Utsuki S, Oka H, Sato S, Shimizu S, Suzuki S, Tanizaki Y, et al.Histological examination of false positive tissue resectionusing 5-aminolevulinic acid-induced fluorescence guidance[discussion 213-4]. Neurol Med Chir (Tokyo). 2007;47:210-3. (Pubitemid 46827890)
4. Feigl GC, Ritz R, Moraes M, Klein J, Ramina K, Gharabaghi A, etal. Resection of malignant brain tumors in eloquent corticalareas: a new multimodal approach combining 5-aminolevulinicacid and intraoperative monitoring. J Neurosurg. 2010;113:352-7.
5. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvert A, et al. The 2007 WHO classification of tumours of thecentral nervous system. Acta Neuropathol. 2007;114:97-109. (Pubitemid 47103521)
6. Kurimoto M, Hayashi N, Kamiyama H, Nagai S, Shibata T, Asahi T, et al. Impact of neuronavigation and image-guidedextensive resection for adult patients with supratentorialmalignant astrocytomas: a single-institution retrospectivestudy. Minim Invasive Neurosurg. 2004;47:278-83. (Pubitemid 39612497)
7. Wirtz CR, Albert FK, Schwaderer M, Heuer C, Staubert A, Tronnier VM, et al. The benefit of neuronavigation forneurosurgery analyzed by its impact on glioblastoma surgery.Neurol Res. 2000;22:354-60. (Pubitemid 30409592)
8. Willems PW, Van der Sprenkel JW, Tulleken CA, Viergever MA, Taphoorn MJ. Neuronavigation and surgery of intracerebraltumours. J Neurol. 2006;253:1123-36.
9. Litofsky NS, Bauer AM, Kasper RS, Sullivan CM, DabbousOH; Glioma Outcomes Project Investigators. Image-guidedresection of high-grade glioma: patient selection factors andoutcome. Neurosurg Focus. 2006;20:E16.
10. Nimsky C, Von Keller B, Schlaffer S, Kuhnt D, Weigel D, Ganslandt O, et al. Updating navigation with intraoperativeimage data. Top Magn Reson Imaging. 2009;19:197-204.
11. Hirschberg H, Samset E, Hol PK, Tillung T, Lote K. Impact ofintraoperative MRI on the surgical results for high-gradegliomas. Minim Invasive Neurosurg. 2005;48:77-84. (Pubitemid 40769552)
12. Rygh OM, Selbekk T, Torp SH, Lydersen S, Hernes TA, Unsgaard G. Comparison of navigated 3D ultrasound findingswith histopathology in subsequent phases of glioblastomaresection. Acta Neurochir (Wien). 2008;150:1033-41.
13. Hefti M, Von Campe G, Moschopulos M, Siegner A, LooserH, Landolt H. 5-aminolevulinic acid induced protoporphyrinIX fluorescence in high-grade glioma surgery: a oneyearexperience at a single institution. Swiss Med Wkly.2008;138:180-5.